13 employees
Verigraft AB is a biotech company that generates personalized tissue-engineered transplants for use in regenerative medicine.
2004
$2.6M
from 1 investors over 1 rounds
VERIGRAFT raised $2.6M on September 1, 2017
Investors: Executive Agency for Small and Medium-sized Enterprises (EASME)